Pfizer: Osteoporosis trials
The registry lists 13 Osteoporosis studies with Pfizer as lead sponsor. 0 are open to participants now and 9 have results posted.
Phase 1 1Phase 2 1Phase 3 6No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual PracticeCompletedNCT01793142Results posted
- Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT01470326Results posted
- Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)CompletedNCT01416194Results posted
- Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.CompletedNCT01293487Phase 1Results posted
- Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal OsteoporosisCompletedNCT00808132Phase 3Results posted
- Study Evaluating Changes In Mammographic Breast DensityCompletedNCT00774267Results posted
- Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMDCompletedNCT00752557Phase 2Results posted
- Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal WomenCompletedNCT00242710Phase 3Results posted
- Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal WomenCompletedNCT00205777Phase 3Results posted
- Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal WomenCompletedNCT00675688Phase 3
- Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal WomenCompletedNCT00481169Phase 3
- Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian WomenCompletedNCT00384072Phase 3
- A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With ForteoCompletedNCT00365924Not applicable